You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 27, 2024

Ranitidine - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

Summary for ranitidine

US Patents:	0
Tradenames:	9
Applicants:	48
NDAs:	85
Drug Master File Entries:	43
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	51
Clinical Trials:	111
Patent Applications:	5
Drug Prices:	Drug price trends for ranitidine
Drug Sales Revenues:	Drug sales revenues for ranitidine
What excipients (inactive ingredients) are in ranitidine?	ranitidine excipients list
DailyMed Link:	ranitidine at DailyMed

Drug Prices for ranitidine

See drug prices for ranitidine

Drug Sales Revenue Trends for ranitidine

See drug sales revenues for ranitidine

Recent Clinical Trials for ranitidine

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Kasr El Aini Hospital	N/A
Menoufia University	Phase 2/Phase 3
Cairo University	N/A

See all ranitidine clinical trials

Generic filers with tentative approvals for RANITIDINE

Applicant	Application No.	Strength	Dosage Form
⤷ Sign Up	⤷ Sign Up	15MG/ML	Solution; Oral

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

US Patents and Regulatory Information for ranitidine

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sandoz	RANITIDINE HYDROCHLORIDE	ranitidine hydrochloride	CAPSULE;ORAL	074655-001	Oct 22, 1997	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sun Pharm Inds Ltd	RANITIDINE HYDROCHLORIDE	ranitidine hydrochloride	TABLET;ORAL	075439-002	Apr 19, 2000		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sandoz	RANITIDINE HYDROCHLORIDE	ranitidine hydrochloride	TABLET;ORAL	074467-001	Aug 29, 1997	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Chattem Sanofi	ZANTAC 150	ranitidine hydrochloride	TABLET;ORAL	021698-001	Aug 31, 2004		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sun Pharm Inds Ltd	RANITIDINE HYDROCHLORIDE	ranitidine hydrochloride	TABLET;ORAL	075132-001	Jan 14, 2000		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ranbaxy	RANITIDINE HYDROCHLORIDE	ranitidine hydrochloride	TABLET;ORAL	075000-001	Jan 30, 1998		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.